About Us

What We Do

News
中

Public Health

Investing in Minds That Will Cure

Why We Exist

We believe the future of medicine begins with the people we empower today. At YongLin Foundation, we are committed to nurturing a new generation of thinkers, scientists, and healers who will transform how diseases are prevented, understood, and cured. By investing in human potential, we are building the intellectual infrastructure Taiwan—and the world—needs to lead in medical innovation.

  • Strategy
  • Areas of focus

Strategy

How We Lead
Through bold partnerships with top academic institutions, YongLin Foundation is creating a vibrant ecosystem that integrates research, technology, and education. We connect disciplines, attract global talent, and equip the next generation with the tools to challenge convention and redefine what’s possible in cancer treatment and beyond.


Areas of focus

National Taiwan University YongLin Institute of Health (NTU-YIH)

Established in 2017, NTU-YIH is a cornerstone of Terry Gou’s “New Century Medical Initiative.” This institute was designed to break silos and spark cross-disciplinary breakthroughs in biomedical science. Under the leadership of former NTU President Pan-Chyr Yang, it serves as a national engine for innovation—advancing R&D, promoting resource-sharing, and building Taiwan’s next-generation biomedical technology cluster.

YongLin Biomedical Engineering Hall

A launchpad for future medicine, this facility supports education, industry, and clinical research across eight strategic sectors: from smart hospitals and medical electronics to biomarkers and cell therapy. Equipped with an optical fiber neural network and a big data center, it is where global research ambition meets state-of-the-art infrastructure—all rooted in Taiwan, all designed to shape the world.

YongLin Scholars Program

World-class minds, homegrown breakthroughs. This program attracts top international researchers while cultivating local talent in cancer medicine and biomedical engineering. Our goal: to position NTUCC as not only Taiwan’s flagship in cancer research, but a global epicenter for discovery, prevention, and treatment.

YongLin Seminar

Since 2014, the YongLin Seminar Series has united the brightest minds in academia, clinical medicine, and industry. These high-impact gatherings spark new ideas, deepen international collaboration, and accelerate progress in some of the most complex challenges in modern cancer research.